SUMMARY
Cerebral deposition of amyloid -protein (A ) is an invariant feature of Alzheimer's disease (AD), and epidemiological evidence suggests that moderate consumption of foods enriched with phenolic compounds reduce the incidence of AD. We previously reported that the phenolic compounds myricetin (Myr) and rosmarinic acid (RA) inhibited A aggregation in vitro and in vivo. To elucidate a mechanistic basis for these results, we analyzed the effects of five phenolic compounds in the A aggregation process and in oligomer-induced synaptic toxicities. We now report that the phenolic compounds blocked A oligomerization, and Myr promoted significant NMR chemical shift changes of monomeric A . Both Myr and RA reduced cellular toxicity and synaptic dysfunction of the A oligomers. These results suggest that Myr and RA may play key roles in blocking the toxicity and early assembly processes associated with A through differently binding.
Alzheimer's disease (AD) has been characterized historically by the accumulation of intraneuronal filaments formed by the microtubule-associated protein tau and of extracellular parenchymal and vascular amyloid deposits largely comprising the amyloid -protein (A ) (1) . Continuing investigations of 2 the pathogenetic relationships among tau, A , and AD suggest that oligomeric forms of A play a seminal role in disease causation (1, 2) . More recent evidence suggests that low n-order oligomers are especially important (3). Townsend et al. found that A trimers fully inhibit long-term potentiation, whereas dimers and tetramers have an intermediate potency (4) . Dimers and trimers from the conditioned medium of amyloid precursor protein (APP)-expressing CHO cells have been found to cause progressive loss of synapses in organotypic rat hippocampal slices (5) . A oligomers extracted from AD brains disrupt synaptic function, and dimers were the smallest oligomers showing activity (6) . Recently, structure-cytotoxicity studies of pure A oligomer populations produced the first determinations of oligomer specific activity (7) , in that dimers, trimers, and tetramers all were significantly more toxic than monomers. Importantly, a non-linear dependence of cytotoxicity on oligomer order was observed. Thus, the most efficacious therapeutic agents should perhaps target monomeric A and prevent its assembly into any sized oligomer (3) . Nature itself may have created useful therapeutic agents of AD. The relevance of this finding to AD has come from French and Danish epidemiological studies suggesting that moderate wine drinking may protect against AD (8, 9) . Investigation of this phenomenon may reveal the answer for wine's protective effects against AD. Classical biochemical fractionation studies have shown that the active components of red wine are phenolic compounds, including resveratrol and the proanthocyanidins (10) . Resveratrol was found to lower significantly the levels of secreted and intracellular A produced in a variety of cell lines by increasing proteasome-mediated A degradation (11) . Interestingly, a related polyphenolic compound, curcumin (Cur), is found in the common spice curry (12) . As with red wine, epidemiologic studies have shown a correlation between curry consumption and decreased AD risk (13) . The concordance of results from these different systems emphasizes the potential importance of elucidating the mechanism through which phenolic compounds may alter A aggregation and toxicity.
Initial mechanistic studies have focused on formation of large aggregates, A fibrils (fA ). Phenolic compounds, such as the wine related polyphenol myricetin (Myr), a major component of curry spice turmeric Cur, its analog rosmarinic acid (RA), nordihydroguaiaretic acid (NDGA), and ferulic acid (FA) inhibit the formation of fA as well as dissociate preformed fibrils by preferentially and reversibly binding to these structures (14) (15) (16) . In cell culture experiments, Myr-treated fA were less toxic than intact fA (14) . Recently, a commercially available grape seed polyphenolic extract, MegaNatural ® , was shown to inhibit significantly the aggregation of A into sodium dodecyl sulfate (SDS)-stable high molecular weight (HMW) oligomers (15-20 monomers) using AD model transgenic animals (Tg2576) (17) . We showed that the phenolic compounds such as Myr, Cur, and RA prevented the development of AD pathology and reduced HMW oligomers in Tg2576 mice (18) .
In the studies reported here, we sought to determine how the phenolic compounds affected A conformational dynamics and the early stages of A assembly. To do so, we analyzed the assembly of the A 42 and A 40 with five phenolic compounds, Myr, FA, NDGA, Cur, and RA ( Fig. 1) using several well-established techniques for studying amyloid formation, including photo-induced cross-linking of unmodified proteins (PICUP), atomic force microscopy (AFM), circular dichroism spectroscopy (CD), and nuclear magnetic resonance (NMR). Next, we examined whether the phenolic compounds reduced A assembly-induced cytotoxicity and synaptic dysfunction using 3-(19)-2,5-diphenyltetrazolium bromide (MTT) assays and electrophysiological assays for long-term potentiation (LTP) and depression (LTD) in hippocampal slices.
EXPERIMENTAL PROCEDURES
Chemicals and reagents -Chemicals were obtained from Sigma-Aldrich Co. (St. Louis, MO) and were of the highest purity available. Water was produced using a Milli-Q system (Nihon Millipore K.K., Japan).
3
Proteins and phenolic compounds -A peptides were synthesized, purified, and characterized as described previously (20, 21) . Briefly, synthesis was performed on an automated peptide synthesizer (Model 433A, Applied Biosystems, CA) using 9-fluorenylmethoxycarbonyl-based methods on pre-loaded Wang resins. Peptides were purified using reverse-phase high-performance liquid chromatography (RP-HPLC). Quantitative amino acid analysis and mass spectrometry yielded the expected compositions and molecular weights, respectively, for each peptide. Purified peptides were stored as lyophilizates at -20°C.
[Met(O) 35 ]A 42 peptide was purchased from Bachem AG (Bubendorf, Switzerland). To prepare peptides for study, A peptide lyophilizates were dissolved at a nominal concentration of 25 or 50 μM in 10% (v/v) 60 mM NaOH and 90% (v/v) 10 mM phosphate buffer, pH 7.4. After sonication for 1 min, the peptide solution was centrifuged for 10 min at 16,000 x g. A stock solution of GST (Sigma-Aldrich, St. Louis, MO) was prepared by dissolving the lyophilizate to a concentration of 250 μM in 60 mM NaOH. Prior to use, aliquots were diluted 10-fold into 10 mM sodium phosphate, pH 7.4. We examined 5-phenolic compounds such as Myr, FA, NDGA, Cur, and RA. They were dissolved in ethanol to a final concentration of 2.5 mM and then diluted with 10 mM phosphate, pH 7.4, to produce concentrations of 5, 10, 25, 50, 100, and 500 μM for CD, PICUP, and AFM, as described previously (20) .
CD -CD spectra of A :compound mixtures were acquired immediately after sample preparation or following 2, 3, 5, or 6 days of incubation. CD measurements were made by removing a 200 μl aliquot from the reaction mixture, adding the aliquot to a 1 mm path length CD cuvette (Hellma, Forest Hills, NY), and acquiring spectra in a J-805 spectropolarimeter (JASCO, Japan). The CD cuvettes were maintained on ice prior to introduction into the spectrometer. Following temperature equilibration, spectra were recorded at 22°C from ~190-260 nm at 0.2 nm resolution with a scan rate of 100 nm/min. Ten scans were acquired and averaged for each sample. Raw data were manipulated by smoothing and subtraction of buffer spectra according to the manufacturer's instructions.
Chemical cross-linking and determination of oligomer frequency distributions -Immediately after their preparation, samples were cross-linked using PICUP, as described (22 Fractions were lyophilized immediately after collection. Reconstitution of the lyophilizates to a nominal concentration of 25 M in 10 mM sodium phosphate, pH 7.4, followed by the SDS-PAGE analysis, showed that removal of reagents and phenolic compounds, lyophilization, and reconstitution did not alter the oligomer composition of any of the peptide populations under study (Fig. S1) .
AFM -Peptide solutions were characterized using a Nanoscope IIIa controller (Veeco Digital Instruments, CA) with a multimode scanning probe microscope equipped with a JV scanner. All measurements were carried out in the tapping mode under ambient conditions using single-beam silicon cantilever probes. A 10 μl aliquot of each peptide lyophilizate, reconstituted to a concentration of 25 μM in 10 mM PBS, pH 7.4, was spotted onto freshly cleaved mica (Ted Pella, Inc., CA), incubated at room temperature for 5 min, rinsed with water, and then blown dry with air. At least four regions of the mica surface were examined to confirm the homogeneity of the structures throughout the sample. Mean particle heights were analyzed by averaging the measures values of eight individual cross-sectional line scans from each image only when the particle structure was confirmed.
NMR spectroscopy -Stock solutions of the five phenolic compounds (2.5 mM), and monomeric, uniformly 15 N-labelled A 42 peptide (0.25 mM) (rPeptide, GA) and A 40 (0.25 mM) were prepared by dissolution (with sonication) in aqueous basic solution (pD 11, 1 ml, 10 mM NaOD) (21) . Aliquots of the A 42 and phenolic solutions were combined and mixed with cold (5°C) phosphate buffer solution (0.5-1.0 ml, 5 mM, pH 7.5) that contained 0.5 mM predeuterated ethylenediamine tetraacetic acid (Na 2 EDTA-d 12 ), and 0.05 mM NaN 3 . The aliquots were varied so that the final peptide:compound concentration ratio was 25 μM : 500 μM. To prevent aggregation, peptide solutions were kept cold (5°C) and standard 1 H-15 N HSQC spectra were obtained within 30-min of the sample preparation. Spectra were obtained at 5 o C with a Bruker Avance-II 900 MHz spectrometer equipped with a TXI cryoprobe (Bruker BioSpin, Inc., CA).
The saturation transfer difference (STD) experiments were obtained with the A 40 (25 μM) alone or with RA or Myr (50 μM) at pH 7.5 and 5°C. Data was acquired at 900.18 MHz using the pulse program (selective irradiation)-(non selective excitation)-(watergate)-(acquisition) (24, 25) . The selective irradiation used a 3.9-s long and weak pulse that was alternatively applied at -0.2 ppm (where there was a peak) and at 30 ppm (where there was no peak), the latter constituting the reference spectra.
The non-selective excitation was achieved with a 90° pulse at the water position (4.7 ppm), and the Watergate 3-9-19 pulse sequence was used to suppress the water signal. Each spectrum was acquired with 128-scans (12-min), and stored separately. The STD was obtained by subtracting the reference spectra from that obtained with irradiation at -0.2 ppm.
All NMR spectra were processed with the NMRPipe (26), Mnova (http://mestrelab.com/software/mnova-nmr/), or CARA (http://cara.nmr.ch) programs using a PC computer.
NMR-based molecular modeling -Atomic coordinates of the NMR/molecular dynamics A 42 structural model were kindly provided by Dr. Chunyu Wang (Rensselaer Polytechnic Institute, NY) (27) . With the model, the regions showing the most pronounced NH chemical shift movements (greater than 0.02 ppm) were revealed using the Swiss PDB Viewer program (28) . These (backbone) regions were labeled with red color and the regions not showing movement with green color.
Cell culture -HEK 293 cells were cultured in 75-cm 2 flasks (Corning Inc., NY) in Dulbecco's modified Eagle's medium (DMEM)(Sigma-Aldrich, St. Louis, MO) containing 10% fetal bovine serum and incubated in a humidified chamber (85% humidity) containing 5% CO 2 at 37°C. One day before peptide sample treatment, the cell culture medium was replaced with serum-free DMEM, and the cells were trypsinized and re-plated onto coated 96-well plates at a final cell density of 20,000 cells/well.
Cytotoxicity assays -We used to test the toxicity of uncross-linked, cross-linked, cross-linked with Myr, and cross-linked with RA of A 42 as assessed in MTT assay. Peptide samples were prepared at A concentrations of 2 μM and 20 μM in 10 mM sodium phosphate, pH 7.4. Aliquots of 50 μl were added to HEK cells to yield final A concentrations of 1 and 10 μM. Twenty hours after the cells were incubated with peptide samples, MTT was added to each well, and the plates were kept in a CO 2 incubator for an additional 2 h. The cells were then lysed by adding lysis solution (50% dimethylformamide, 20% SDS at pH 4.7) and were incubated overnight. The degree of MTT reduction (i.e., cell viability) in each sample was subsequently assessed by measuring absorption at 590 nm at room temperature using a plate reader (PerkinElmer, Turku, Finland). Controls included medium with sodium phosphate ("negative") and 1 μM poly-L-lysine [ave. MW : 75000 Da] (Sigma-Aldrich) ("maximal positive"). Background absorbance values, as assessed from cell-free wells, were subtracted from the absorption values of each test sample. The absorbance measured from the three wells were averaged, and reported as mean ± S.E. percentage of cell viability V = 100 -((A A -A medium )/(A poly-L-lysine -A medium )) 100
where A A , A medium , and A poly-L-lysine were absorbance values from A -containing samples, medium alone, or poly-L-lysine alone, respectively.
Electrophysiology -The fEPSPs were recorded from the CA1 region of acute hippocampal slices derived from C57BL/6 mice (male, 4-5 wk of age). The procedures for slice preparation and electrophysiological recording were described previously (29) . Briefly, 300 μm thickness transverse hippocampal slices were placed in a physiological chamber perfused with artificial cerebrospinal fluid (ACSF; 125 mM NaCl, 3.5 mM KCl, 1.25 mM NaH 2 PO 4 , 25 mM NaHCO 3 , 2.0 mM MgSO 4 , 2.0 mM CaCl 2 and 20 mM glucose, aerated with a mixture of 95% O 2 and 5% CO 2 ) at a rate of 1 ml/min at 30ºC. Shaffer collaterals/commissural bundle in the CA3 hippocampal subfield were stimulated using a bipolar stainless steel wire electrode at 20-sec intervals throughout the experiment. The fEPSPs were recorded from the stratum radiatum in the CA1 hippocampal subfield using a sharp glass electrode (2-6 M , filled with 2 M NaCl). LTP was induced by tetanic stimulation delivered at 100 Hz for 1 sec. LTD was induced by low frequency 450 paired-pulse stimulation (50 msec paired-pulse interval, 1 Hz) for 7.5 min. LTD was induced only under the presence of cross-linked A 42 oligomer in this condition (see Results in detail). Each A 42 sample (500 nM in 0.3 mM NaOH in ACSF) or vehicle (0.3 mM NaOH in ACSF) was applied for 20 min so that A 42 sample/vehicle application overlapped and coterminated with conditioning stimulation for LTP or LTD. The evoked potential was amplified (x1000), filtered (0.1-1000 Hz), digitized (20 kHz) and stored in a computer for off-line analysis using PowerLab system (AD Instruments, Colorado Springs, CO). LTP and LTD values were presented as the percentage of average fEPSPs slope relative to the mean value of the baseline before conditioning stimulation.
Statistical analysis -One-way factorial ANOVA followed by Tukey-Kramer post hoc comparisons were used to determine statistical significance among data sets. These tests were 6 implemented within GraphPad Prism software (GraphPad Software). Significance was defined as p<0.05.
RESULTS
A oligomerization -To determine whether the five phenolic compounds blocked formation of low n-order A oligomers, we used PICUP, a photochemical cross-linking method that is rapid, efficient, requires no structural modification of A , and accurately reveals the oligomerization state of A (22) . In the absence of cross-linking, only A 40 monomers ( Fig. 2A) and A 42 monomers and trimers (Fig. 2B) were observed. The A 42 trimer band has been shown to be an SDS-induced artifact (22) . Following cross-linking, and as reported previously (22), A 40 existed predominately as a mixture of monomers and oligomers of order 2-4 ( Fig. 2A,) whereas A 42 comprised predominately monomers and oligomers of order 2-6 (Fig. 2B) .
When 10 μM Myr was mixed with A 40 at a peptide:compound ratio of 5:2, oligomerization was blocked slightly (Fig. 2A) . The intensity of tetramer band was decreased. When 100 μM Myr was mixed with A 40 at a peptide:compound ratio of 1:4, oligomerization was blocked almost completely ( Fig. 2A) . The effect of Myr on A 42 oligomerization was equally significant (Fig. 2B) . When 10 μM Myr was mixed with A 42 at a peptide:compound ratio of 5:2, oligomerization was blocked moderately. The pentamer and hexamer bands disappeared, and the intensity of tetramer band markedly decreased (Fig.  2B) . At peptide:compound ratio of 1:4, Myr produced oligomer distributions almost identical to those of untreated A 42, consistent with an essentially complete inhibition of oligomerization (Fig. 2B) . When 10 or 100 μM RA was mixed with A 40 or A 42 at the same ratios as used above, comparable effects were observed on A oligomerization ( Figs. 2A and B) .
With A 40:FA at a 5:2 ratio, no inhibition of oligomerization was observed ( Fig. 2A) . At a higher concentration of FA (A 40:FA, 1:4), the trimer and tetramer bands disappeared, and the intensity of dimer band decreased ( Fig. 2A) . Similarly, with A 42:FA at a 5:2 ratio, no inhibition of the oligomerization was observed (Fig. 2B) , while at higher concentration of FA (A 42:FA, 1:4), the pentamer and hexamer bands disappeared, and the intensity of tetramer band weakened (Fig. 2B) .
When 10 or 100 μM NDGA was mixed with A 40 or A 42, similar strong effects was observed on A oligomerization ( Figs. 2A and  B) .
When 10 μM Cur was mixed with A 40 at a peptide:compound ratio of 5:2, no inhibition of oligomerization was observed ( Fig. 2A) . When 100 μM Cur was mixed with A 40 at a peptide:compound ratio of 1:4, oligomerization was blocked slightly (Fig. 2A) . The intensity of tetramer band was decreased slightly. Similarly, when 10 μM Cur was mixed with A 42 at a peptide:compound ratio of 5:2, no inhibition of oligomerization was observed (Fig. 2B) . At higher concentration of Cur (A 42:Cur, 1:4), oligomerization was blocked slightly (Fig. 2B) . The intensities of dimer, pentamer, and hexamer band were decreased slightly.
We confirmed dose-dependency of these inhibitions (Fig.  S2) . 35 ]A 42 existed predominately as a mixture of monomers and oligomers of order 2-5 (Fig. S3) . When 10 or 100 μM Myr was mixed with [Met(O) 35 ]A 42, oligomerization was blocked significantly (Fig.  S3) . The intensity of trimer, tetramer and pentamer bands disappeared, and the intensity of dimer band markedly decreased. Similar effects were observed when 10 or 100 μM RA was mixed with [Met(O) 35 ]A 42 (Fig. S3) . A potential problem relates to the possibility 7 that the strong inhibition of A oligomerization could have resulted from an alternative compound, which may form from a possible side-reaction of the inhibitor and the PICUP sensitizer. To evaluate this possibility, cross-linking reactions also were performed on glutathione-S-transferase (GST; ~26 kDa), a positive control for the cross-linking chemistry (31) . Uncross-linked GST exhibited an intense monomer band and a relatively faint dimer band (Fig. 2C) . Cross-linking produced an intense dimer band, expected because GST exists normally as a homodimer, as well as higher-order cross-linked species. No alterations in GST cross-linking were observed in the presence of Myr, FA, NDGA, Cur, or RA at either of the two protein:compound ratios tested, 5:2 or 1:4 (Fig. 2C) . Thus, the significant inhibition of A 40 and A 42 oligomerization is from a direct interaction with the phenolic compounds.
A assembly morphology -To determine the morphology of the small assemblies present following PICUP of A 40 and A 42 with or without phenolic compounds, we used AFM. The height of uncross-linked A 40 was 0.23 ± 0.03 nm (Fig. 2D and Table S1 ). Following PICUP, the height of A 40 oligomers became 0.90 ± 0.05 nm (Fig. 2F and Table S1 ). The height of uncross-linked A 42 was 0.33 ± 0.02 nm (Fig. 2E and Table S1 ). Following PICUP, the height of A 42 oligomers became 1.39 ± 0.09 nm (Fig. 2G and Table S1 ). These morphologies are not inconsistent with our previous findings (7, 23) . When A 40 was cross-linked with Myr at a compound:peptide ratio of 4:1, the height of treated A 40 decreased to 0.32 ± 0.03 nm (Fig. 2H and Table  S1 ). When A 40 was cross-linked with RA at a compound:peptide ratio of 4:1, the height of treated A 40 decreased to 0.42 ± 0.04 nm (Fig.  2J and Table S1 ). Similarly, when A 42 was cross-linked with Myr or RA at a compound:peptide ratio of 4:1, the height of treated A 40 decreased clearly (Figs. 2I, 2K and Table S1 ).
A secondary structure dynamics -The above oligomerization studies revealed effects of the phenolic compounds at the initial stages of peptide self-association. To examine whether the phenolic compounds altered the secondary structure of the A , we undertook CD studies (Fig. 3) . A 40 and A 42, incubated alone, produced initial spectra characteristic of statistical coils (SC) (Figs. 3A and B) . The major feature of these spectra was a large magnitude minimum centered at ~198 nm. A 40 displayed substantial secondary structure changes between days 3-5 that were consistent with previously reported SC -helix/ -sheet -sheet transitions associated with monomer protofibril fibril assembly (20) . The A 42 system displayed similar structural changes, although, as expected, these changes occurred at much faster rate (0-2 days). When A 40 or A 42 were incubated with Myr at a compound:peptide ratio of 4:1, no such transitions were observed (Figs. 3C and D) . Similarly, no such transitions were observed in the presence of RA (Figs. 3E and F) . All spectra of A 40 and A 42 treated by Myr or RA revealed populations of conformers that were largely statistical coil.
NMR studies -The binding between the phenolic compounds and the A 42 was explored using NMR spectroscopy, a well-accepted tool for obtaining atomic level aspects of protein structure and ligand binding. The sample preparation protocol and lower NMR probe temperature (5°C) ensured that the A 42 remained monomeric during the entire data acquisition period (21, 32 Fig. 4 are superimposed HSQC spectra of the A 42 alone (black crosspeaks) and the A 42 containing RA (Fig. 4A , red crosspeaks) and Myr (Fig. 4B, red crosspeaks) . Because the cross peaks of the superimposed spectra in Fig. 4A Fig. 4B ) indicative of binding. The most pronounced movements (0.02-0.05 ppm) were in the 1 H dimension and were among the R5, V12, H13, K16, L17, V18, F19, F20, A21, E23, D23, I31, and I32 residues. Besides movements, NH peak broadening occurred with R5, V12, K16, and V18, suggesting that the binding may be stronger with these residues. Less peak movements were seen with FA, NDGA, and Cur, and were not localized to any specific peptide region (Fig. S4) .
The binding of RA and Myr were further explored using STD experiments, which is a well-established homonuclear NMR technique that permits detection of transient binding of small molecule ligands to macromolecular receptors. Notably, the STD has been used to discriminate ligand binding to monomeric or oligomeric states of the A that co-exist in solution (24, 33, 34) . In the STD, two separate spectra are obtained and then subtracted, where one spectra involves saturation of a resonance that belongs to the receptor (in this case the A ), while the second spectra involves saturation in a far-removed region that does not contain signals. The presence and strength of signals in the STD is indicative of binding.
Shown in Fig. S5 are three groups of spectral data: A 40 alone (Figs. S5A and B) , A 40 with RA (Figs. S5C and D) , and A 40 with Myr (Figs. S5E and F) . As expected, the STD spectra of A 40 alone (Fig. S5B) has no signals. By contrast, spectra containing RA (Fig.  S5D) has extremely weak, barely-discernable peaks while that containing Myr (Fig. S5F) has obvious peaks. Because solution NMR detects only monomeric A (21, 24) , these data demonstrate that Myr binds to monomeric A while RA does not bind or binds very weakly. Overall, these results are consistent with the above HSQC data.
Highlighted in Fig. 5 are molecular models of the A 42 that were obtained from a combined molecular dynamics and NMR approach (27) . In solution, the A 42 adopts a rapidly equilibrating ensemble of conformations, which, for the monomeric aggregation state are predominately unstructured (21, 32) . These models effectively depict a single, highly-populated conformation that has -hairpin at residues I31-L34 and G37-I41. The regions showing phenol-induced chemical shifts are colored in red, and because RA did not promote changes (Fig. 4A) , only the green unlabeled backbone structure is shown. It is obvious that Myr causes extensive changes throughout the sequence, with continuous 9-and 3-residue spans at K16-V24 and I31-G33. By contrast, FA, NDGA, and Cur interactions are more limited, and interestingly occur at identical residues: R5, S8, G9, H133, K16, D23, and I31 (Cur also causes shifts of L17). With the exception of RA, all phenolic compounds have a proclivity for polar or charged amino acid residues.
Cellular toxicity -The ability of Myr and RA to inhibit formation of low-n A oligomers suggested that it might be useful in blocking the A -mediated cellular toxicity. To address this possibility, we performed MTT assays (35) and probed the cellular metabolism of human embryonic kidney (HEK) 293 cells. The MTT assay constitutes a rapid and sensitive method for determination of gross A toxicity in cultures of dissociated cells (36) .
Previous short duration incubation experiments established that the cross-linked A 40 and A 42 oligomers were more toxic than uncross-linked oligomers (7, 23) . In the present study, we explored the immediate consequences (i.e., no incubation time) on the viability of cells. Overall, the results are consistent with the previous study, in that uncross-linked and cross-linked A 42 oligomers (1 μM concentration and added immediately to the cells) showed cell viabilities of ~95% and ~79%, respectively. Thus, the cross-linked oligomers were significantly more toxic than uncross-linked oligomers (p < 0.05) (Fig. S6) .
Repeating the experiments with Myr showed almost a complete loss of cell toxicity, with the cross-linked oligomer with Myr producing slightly lower toxicity (p < 0.05). Using RA (instead of Myr) also reduced the toxicity to 6%, which was a major reduction relative to cross-linked A 42 (p < 0.05).
Similar observations were made in experiments with A 42 at higher concentrations 9 (10 μM) (Fig. S6) . Uncross-linked and cross-linked A 42 displayed ~53% and ~44% cell viability levels, respectively, revealing a trend towards higher toxicity with cross-linked A 42. Myr and RA treatment increased cell viability significantly, 69% and 64% (p < 0.01) higher, respectively. In summary, regardless of the cross-linked state, Myr and RA are effective in disrupting the cellular toxicity associated with low-n A 42 oligomers.
Electrophysiology -To obtain an index of A 42-induced functional alteration of synaptic transmission, we analyzed LTP and LTD in the CA1 region of mouse hippocampal slices. Synaptic current strength was estimated from field excitatory postsynaptic potentials (fEPSP) slope (Figs. 6A and B) . The vehicle group indicated LTP by tetanus stimulation (150 ± 6.7%). Cross-linked A 42 completely inhibited induction of LTP (97.5 ± 7.6%) without any alterations in baseline transmission. In contrast, cross-linked A 42 treated with Myr and RA induced LTP comparable to that of the vehicle alone (157 ± 5.1% and 144 ± 11.1%, respectively). Uncross-linked A 42 also induced LTP comparable to that in the vehicle (140 ± 10.1%). Fig. 6C shows differences in LTP induction among the five treatment groups. There was a significant group effect on %fEPSP slope [F(4,22) = 6.295, p < 0.005]. The post-hoc tests showed that %fEPSPs slope in the cross-linked A 42 group was significantly lower than those in the other four groups (Fig. 6C , **p<0.01), indicating that cross-linked A 42 induced LTP suppression, but cross-linked A 42 treated with Myr and RA did not.
Low frequency conditioning stimulation (1 Hz, 450 paired-pulse) induced a transient decrease in %fEPSP slope beyond the 95% lower confidence limit of the baselines in all groups (Figs. 6D and E) . This short-term decrease in synaptic transmission gradually recovered, and the vehicle group showed %fEPSP slope comparable to the baseline level (104.2 ± 10.1%) during 50-60 min after LTD induction. The cross-linked A 42 with Myr and RA as well as uncross-linked A 42 groups also showed %fEPSP slopes comparable to the baseline level (102 ± 2.6, 94 ± 4.2, and 105 ± 9.4%, respectively) during 50-60 min after LTD induction. However, the cross-linked A 42 group showed LTD (69 ± 6.6%) by low frequency conditioning stimulation. Fig. 6F shows differences in LTD induction among the five treatment groups. There was a significant group effect on %fEPSP slopes [F(4,20) =6.925, p < 0.005]. The post-hoc tests showed that fEPSP in the cross-linked A 42 group was significantly lower than that in the other four groups (Fig. 6F, *p < 0 .05, **p < 0.01), indicating that cross-linked A 42 induced LTD facilitation, but not cross-linked A 42 treated with Myr and RA.
DISCUSSION
We previously reported that phenolic compounds are effective in vitro inhibitors of fA formation and could destabilize preformed fA (14) (15) (16) . Our subsequent in vivo work with Tg2576 mice established that Myr and RA reduced the amount of A oligomers in the brain and prevented the development of AD pathology (18) . The purpose of the present study was to unravel chemical and neurophysiological bases for these effects, which could accelerate the development of more effective aggregation inhibitors. Fig. S7 presents a summary of how the polyphenols interfere with A aggregation. The monomer soluble oligomer soluble -sheet oligomer protofibril mature fibril is generally recognized as the normal "on-pathway" process associated with plaque formation of the A and other amyloid forming proteins. The PICUP studies revealed that all five phenolic compounds dose-dependently inhibited A 40 and A 42 later-stage oligomerization, and the PICUP method requires that monomers be in close proximity for covalent cross-linking to occur.
Mechanism of Polyphenol Inhibition to Amyloid Formation -
The CD studies showed that Myr and RA stabilized A populations comprising mostly random coil and inhibited SC -sheet conversion, which was consistent with the PICUP data. However, at the atomic level, NMR showed that Myr and RA behave differently, in that Myr shows significant binding to monomeric A 42, whereas RA does not bind to the monomer. This result is intriguing, in that it is possible that RA could prevent aggregation by binding with non-NMR detectable early-formed oligomers (dimers, trimers, etc.) (37) , and in doing so prevents neurotoxicity by binding to an exposed toxic structural motif. Other A binding compounds bind in a similar manner, including human serum albumin (33) , apolipoprotein E3 (38) , and alcohol dehydrogenase (39) . Another possibility is that RA binds to distinct monomer conformers/structures that in turn inhibit oligomerization (40) .
The NMR studies also established that Myr, NDGA, FA, and Cur bind to localized or specific monomeric A peptide regions (Fig. 5) , which are R5, S8, G9, H13, K16, D23, and I31. The polyphenol (-)-epigallocatechin gallate prevents -synuclein ( S) (41) and A 42 aggregation by also binding to small (localized) amino acid regions. Related work (42) reported that the flavonoid baicalein stabilized a partially folded conformer of S that existed within oligomeric assemblies. Conway et al. (43) showed that dopamine or levodopa inhibits the fibrillization of S filaments, presumably through stabilization of S into protofibrillar structures unable to form fibrils. Taniguchi et al. (44) reported the formation of tau oligomers in the presence of phenothiazines, polyphenols, or porphyrins. In each of these cases, the inhibitors stabilized oligomeric states, in which the respective protein maintained at least a partial fold. For A , if the "oligomer cascade" hypothesis is true, (2) aggregation inhibitors that stabilize oligomers could produce peptide populations of enhanced toxicity. The observation that some of the phenolic compounds bind monomeric A and prevent its oligomerization is a particularly important feature.
Polyphenol Inhibition of Neuronal Toxicity and
Relationship to In Vivo Studies -With our previous Tg2576 mice study (18) , RA was very promising because it inhibited both HMW A oligomerization and A deposition, while FA did not inhibit either process. However, our present in vitro studies demonstrate that all phenolic compounds (including FA) prevent low order (< 10 monomers) oligomer formation. This discrepancy could be due to the non-specific nature of the A11 antibody that was used to detect oligomers in the Tg2576 mice (18) , particularly when compared to cross-linked oligomers detected by the PICUP. Similar findings were reported by Necula et al., (45) where dot blot assays with the A11 antibody showed that Myr, NDGA, and Cur inhibited HMW A oligomerization but not fibrillization.
Myr and RA decreased A oligomer-induced synaptic toxicities using LTP and LTD assays of hippocampal slices. LTP and LTD are considered important neurophysiological models of memory and learning and are used as experimental models of neuronal plasticity (46) . Townsend et al. found that A trimers fully inhibit LTP, whereas dimers and tetramers have an intermediate potency (4) . Dimers and trimers from the conditioned medium of APP-expressing CHO cells have been found to cause progressive loss of synapses in organotypic rat hippocampal slices (5) . A oligomers extracted from AD brains potently inhibited LTP and enhanced LTD, indicating disruption of synapse structure and function (6) . Our present work is consistent with previous studies (4) (5) (6) , where A oligomers suppressed LTP and facilitated LTD induction. Both suppression of LTP and facilitation of LTD induction in the hippocampal CA1 subfield suggests that memory formation is disturbed by A oligomers. In contrast, A monomers resulting from reaction with phenolic compounds did not induce such effects. These findings suggest that phenolic compounds have preventive effects on A -induced memory deficits. Recent work suggested that A -induced inhibition of LTP was due to a decrease in density of the NR2B subunit of NMDA receptor at the postsynaptic membrane, and facilitation of LTD was ascribed to an increase in glutamate concentration at the synaptic cleft (47, 48) . These studies suggest that A toxicity could selectively affect these synaptic functions with usual cell functions relatively intact in brief exposure. Therefore, deficits in A -induced neuronal plasticity observed in the present study might be related to early neurophysiological alterations prior to histopathological changes such as neuronal loss and brain atrophy in AD.
Alternative Mechanisms and Benefits of
Polyphenol Treatment for AD -The benefits afforded by certain polyphenols to humans or in animal studies (18) may not be just from an anti-amyloid mechanism. It could happen that in some cases the polyphenols may promote A Met35 red A Met35 ox oxidation, even though we did not detect this in the present in vitro studies. Leong et al. (49) reported that dopamine could oxidize methionine of S peptide, and in the process alter the aggregation properties of the protein.
Myr has antioxidant, anti-inflammatory, anticarcinogen, and antiviral ativities (50) , and can likewise act as a -secretase inhibitor that reduces A production in a cell cultures (51) . FA protects neurons against A -induced oxidative stress and neurotoxicity in vitro (52) , and long-term administration protects mice against A -induced learning and memory deficits in vivo. In fact, it has been now firmly established that all polyphenols have related biological activities, most of which are beneficial in vivo.
Another possibility is that the polyphenols could slow down normal age-related events such as synaptic dysfunction, and in doing so prevent microglial activation and attendant inflammatory responses that lead to neuronal loss and dementia (53) . It is also possible that the beneficial effects may not come from the polyphenols themselves, but rather from polyphenol metabolites, which can be generated by microbial enzymes in the colon (54) . Once produced, these metabolites could enter the brain and reduce the inflammation associated with AD.
Conclusions -Our results established that the phenolic compounds inhibit the oligomerization and the SC -sheet conversion of the A 40 and A 42, while NMR revealed possible binding interaction sites of the phenolic compounds. In addition, the MTT, LTP and LTD assays established that the phenols inhibit A oligomer-induced cellular and synaptic toxicites. While the exact in vivo mechanism behind the benefits of polyphenols remains to be established, the present data, coupled with previously reported antioxidant and ameliorative effects, suggest that phenolic compounds are worthy therapeutic candidates for AD. 
